<https://www.cancertherapyadvisor.com/author/james-nam-pharmd/#author>
<http://schema.org/image>
<https://www.cancertherapyadvisor.com/home/cancer-topics/lymphoma/fda-expands-tisagenlecleucel-indication-to-include-relapsed-refractory-b-cell-lymphomas/>